Circulating microRNAs: A potential role in diagnosis and prognosis of acute myocardial infarction

Disease Markers

Volumn 35, Issue 5, 2013, Pages 561-566

  Sayed, Ali Sheikh Md ^a   Xia, Ke ^a,b   Yang, Tian Lun ^a   Peng, Jun ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 208; MICRORNA 499; TROPONIN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; BLOOD; HUMAN; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; SERUM;

BIOLOGICAL MARKERS; HUMANS; MICRORNAS; MYOCARDIAL INFARCTION; PROGNOSIS; RNA STABILITY;

EID: 84890348671     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/217948     Document Type: Review

References (46)

1. H. D.White and D. P. Chew, "Acute myocardial infarction," The Lancet, vol. 372, no. 9638, pp. 570-584, 2008.
2. V. L. Roger, A. S. Go, D. M. Lloyd-Jones et al., "Heart disease and stroke statistics-2011 update: a report from the American heart association," Circulation, vol. 123, no. 4,pp. e18-e209, 2011.
3. B. Lindahl, "Acute coronary syndrome-the present and future role of biomarkers," Clinical Chemistry and Laboratory Medicine, vol. 23, no. 3, pp. 1-8, 2013.
4. S. S. C. Chim, T. K. F. Shing, E. C.W.Hung et al., "Detection and characterization of placental microRNAs in maternal plasma," Clinical Chemistry, vol. 54, no. 3, pp. 482-490, 2008.
5. G. K.Wang, J.Q. Zhu, J. T. Zhang et al., "Circulating microRNA: a novel potential biomarker for early diagnosis of acutemyocardial infarction in humans," European Heart Journal, vol. 31, no. 6, pp. 659-666, 2010.
6. C. Widera, S. K. Gupta, J. M. Lorenzen et al., "Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome," Journal of Molecular and Cellular Cardiology, vol. 51, no. 5, pp. 872-875, 2011.
7. S. Fichtlscherer, S. de Rosa, H. Fox et al., "Circulating microRNAs in patients with coronary artery disease," Circulation Research, vol. 107, no. 5, pp. 677-684, 2010.
8. A. J. Tijsen,E.E.Creemers, P. D.Moerland et al., "MiR423-5p as a circulating biomarker for heart failure," Circulation Research, vol. 106, no. 6, pp. 1035-1039, 2010.
9. Z. W. Pan, Y. J. Lu, and B. F. Yang, "MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases," Acta Pharmacologica Sinica, vol. 31, no. 1, pp. 1-9, 2010.
10. D. Baek, J. Villén, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel, "The impact of microRNAs on protein output," Nature, vol. 455, no. 7209, pp. 64-71, 2008.
11. E. M. Small and E. N. Olson, "Pervasive roles of microRNAs in cardiovascular biology," Nature, vol. 469, no. 7330, pp. 336-342, 2011.
12. J. Skog, T. Würdinger, S. van Rijn et al., "Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers," Nature Cell Biology, vol. 10, no. 12, pp. 1470-1476, 2008.
13. G. Camussi, M. C. Deregibus, S. Bruno, V. Cantaluppi, and L. Biancone, "Exosomes/microvesicles as a mechanism of cell-tocell communication," Kidney International, vol. 78, no. 9, pp. 838-848, 2010.
14. N.Kosaka, H. Iguchi, Y. Yoshioka, F. Takeshita, Y. Matsuki, and T. Ochiya, "Secretory mechanisms and intercellular transfer of microRNAs in living cells," The Journal of Biological Chemistry, vol. 285, no. 23, pp. 17442-17452, 2010.
15. M. P.Hunter,N. Ismail, X. Zhanget al., "DetectionofmicroRNA expression in human peripheral blood microvesicles," PLoS ONE, vol. 3, no. 11,Article ID e3694, 2008.
16. S. Gilad, E. Meiri, Y. Yogev et al., "Serum microRNAs are promising novel biomarkers," PLoS ONE, vol. 3, no. 9, Article ID e3148, 2008.
17. X. Chen, Y. Ba, L.Ma et al., "Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases," Cell Research, vol. 18, no. 10, pp. 997-1006, 2008.
18. A. Turchinovich, L. Weiz, A. Langheinz, and B. Burwinkel, "Characterization of extracellular circulating microRNA," Nucleic Acids Research, vol. 39, no. 16, pp. 7223-7233, 2011.
19. N. B. Y. Tsui, E. K. O. Ng, and Y. M. D. Lo, "Stability of endogenous and added RNA in blood specimens, serum, and plasma," Clinical Chemistry, vol. 48, no. 10, pp. 1647-1653, 2002.
20. K. Wang, S. Zhang, J. Weber, D. Baxter, and D. J. Galas, "Export of microRNAs and microRNA-protective protein by mammalian cells," Nucleic Acids Research, vol. 38, no. 20, pp. 7248-7259, 2010.
21. K. B.Margulies, "MicroRNAs as novel myocardial biomarkers," Clinical Chemistry, vol. 55, no. 11, pp. 1897-1899, 2009.
22. E. van Rooij, L. B. Sutherland, X. Qi, J. A. Richardson, J. Hill, and E. N. Olson, "Control of stress-dependent cardiac growth and gene expression by a microRNA," Science, vol. 316, no. 5824, pp. 575-579, 2007.
23. T. E. Callis, K. Pandya, H. Y. Seok et al., "MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice," Journal of Clinical Investigation, vol. 119, no. 9, pp. 2772-2786, 2009.
24. A. P. Malizia and D. Z. Wang, "MicroRNAs in cardiomyocyte development," Wiley Interdisciplinary Reviews: Systems Biology and Medicine, vol. 3, no. 2, pp. 183-190, 2011.
25. X. Ji, R. Takahashi, Y. Hiura, G. Hirokawa, Y. Fukushima, and N. Iwai, "Plasma miR-208 as a biomarker of myocardial injury," Clinical Chemistry, vol. 55, no. 11, pp. 1944-1949, 2009.
26. O. Gidlöf, P. Andersson, J. van der Pals, M. Götberg, and D. Erlinge, "Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples," Cardiology, vol. 118, no. 4, pp. 217-226, 2011.
27. M. F. Corsten, R. Dennert, S. Jochems et al., "Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease," Circulation: Cardiovascular Genetics, vol. 3, no. 6, pp. 499-506, 2010.
28. T. Adachi, M. Nakanishi, Y. Otsuka et al., "Plasma microRNA 499 as a biomarker of acute myocardial infarction," Clinical Chemistry, vol. 56, no. 7, pp. 1183-1185, 2010.
29. Y.Q. Li, M. F. Zhang, H. Y.Wen et al., "Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acutemyocardial infarction," Clinics, vol. 68, no. 1, pp. 75-80, 2013.
30. J. T. C. Shieh, Y. Huang, J. Gilmore, and D. Srivastava, "Elevated miR-499 levels blunt the cardiac stress response," PLoS ONE, vol. 6, no. 5, Article ID e19481, 2011.
31. Y. Devaux, M. Vausort, E. Goretti et al., "Use of circulating microRNAs to diagnose acute myocardial infarction," Clinical Chemistry, vol. 58, no. 3, pp. 559-567, 2012.
32. F. Olivieri, R. Antonicelli, M. Lorenzi et al., "Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction," International Journal of Cardiology, vol. 167, no. 2, pp. 531-536, 2013.
33. O. Gidlöf, J. G. Smith, K. Miyazu et al., "Circulating cardioenriched microRNAs are associated with long-term prognosis following myocardial infarction," BMC Cardiovascular Disorders, vol. 13, article 12, 2013.
34. J. Ai, R. Zhang, Y. Li et al., "Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction," Biochemical and Biophysical Research Communications, vol. 391, no. 1, pp. 73-77, 2010.
35. Y. D'Alessandra, P. Devanna, F. Limana et al., "Circulating microRNAs are new and sensitive biomarkers of myocardial infarction," European Heart Journal, vol. 31, no. 22, pp. 2765-2773, 2010.
36. Y. Cheng, N. Tan, J. Yang et al., "A translational study of circulating cell-free microRNA-1 in acute myocardial infarction," Clinical Science, vol. 119, no. 2, pp. 87-95, 2010.
37. B. Meder, A. Keller, B. Vogel et al., "MicroRNA signatures in total peripheral blood as novel biomarkers for acutemyocardial infarction," Basic Research in Cardiology, vol. 106, no. 1, pp. 13-23, 2011.
38. C. van Solingen, L. Seghers, R. Bijkerk et al., "Antagomirmediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis," Journal of Cellular and Molecular Medicine, vol. 13, no. 8, pp. 1577-1585, 2009.
39. P. Mocharla, S. Briand, G. Giannotti et al., "AngiomiR-126 expression and secretion from circulating CD34+ and CD14+ PBMCs: role for proangiogenic effects and alterations in type 2 diabetics," Blood, vol. 121, no. 1, pp. 226-236, 2013.
40. G. Long, F. Wang, Q. Duan et al., "Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acutemyocardial infarction," International Journal of Biological Sciences, vol. 8, no. 6, pp. 811-818, 2012.
41. S. de Rosa, S. Fichtlscherer, R. Lehmann, B. Assmus, S. Dimmeler, and A. M. Zeiher, "Transcoronary concentration gradients of circulating MicroRNAs," Circulation, vol. 124, no. 18, pp. 1936-1944, 2011.
42. A. Zampetaki, P. Willeit, L. Tilling et al., "Prospective study on circulating MicroRNAs and risk of myocardial infarction," Journal of theAmerican College of Cardiology, vol. 60, no. 4, pp. 290-299, 2012.
43. R.Wang, N. Li, Y. Zhang, Y. Ran, and J. Pu, "Circulating micro RNAs are promising novel biomarkers of acute myocardial infarction," InternalMedicine, vol. 50,no. 17,pp. 1789-1795, 2011.
44. M. R. Zile, S. M. Mehurg, J. E. Arroyo, R. E. Stroud, S. M. DeSantis, and F. G. Spinale, "Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients aftermyocardial infarction," Circulation: Cardiovascular Genetics, vol. 4, no. 6, pp. 614-619, 2011.
45. G. Long, F.Wang,Q. Duan et al., "Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction," PLoS ONE, vol. 7, no. 12, Article IDe50926, 2012.
46. J.Fang, X.W. Song, J.Tianet al., "OverexpressionofmicroRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes," Apoptosis, vol. 17, no. 4, pp. 410-423, 2012.